Foresite Capital

Foresite Capital is a private equity firm in California that provides catalytic capital to transformative healthcare companies at all stages. Founded 2011 in San Francisco, California, United States by Jim Tananbaum, this private equity firm invests in private equity, early stage ventures and late stage ventures. Its portfolio companies include Genapsys, Aimmune Therapeutics, Generation Bio, Element Biosciences, and Kinnate Biopharma. As of February 2020, Foresite Capital has made 66 investments. Their most recent investment was on Jan 11, 2020, when Generation Bio raised $110M. Foresite Capital has had 27 exits. Foresite Capital's most notable exits include Aimmune Therapeutics, Twist Bioscience, and Alector. The company has raised 4 funds, their latest being Foresite Capital Fund IV. This fund was announced on May 3, 2018 and raised a total of $668M. The company prefers to invest in the healthcare, therapeutics, devices, diagnostics and services sectors.